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ABSTRACT
Background and Objectives: A renewed interest in the
supra cervical approach to hysterectomy has created a
cohort of patients with a retained cervix at risk of persis-
tent symptoms requiring a subsequent trachelectomy. The
objective of this study was to evaluate the efficacy of
robotic trachelectomy after a previous supracervical hys-
terectomy.
Methods: This is a retrospective chart review of women
who had robotic trachelectomy after supracervical hyster-
ectomy for benign gynecologic disease from January 2009
through October 2014.
Results: Eleven patients underwent robotic trachelec-
tomy for benign conditions during the observed period.
Prior supracervical hysterectomy had been performed for
pelvic pain (8/11, 73%), abnormal uterine bleeding (7/11,
64%), and dysmenorrhea (5/11, 45%). In 10 of 11 patients,
the symptoms leading to robotic trachelectomy were the
same as those leading to supracervical hysterectomy. The
time from hysterectomy to recurrence of symptoms
ranged from 0.5 to 26 months (median, 6), whereas the
time interval from previous surgery to robotic trachelec-
tomy ranged from 1 to 57 months (median, 26). Mean age
and body mass index at robotic trachelectomy were 42 
5.4 years and 32  6.1 kg/m2. Mean length of surgery was
218  88 minutes (range, 100–405). There was 1 major
postoperative complication involving bladder perforation
and subsequent vesicovaginal fistula (VVF). Endometrio-
sis was seen in 27% of pathologic specimens and cervicitis
in another 27%; 45% showed normal tissue histology. In 6
(55%) cases, symptoms leading to trachelectomy resolved
completely after surgery, and the other 5 (45%) patients
reported a significant improvement.
Conclusions: Although trachelectomy can be a challeng-
ing surgery, our experience suggests that the robotic ap-
proach may be a valuable means of achieving safe and
reproducible outcomes.
Key Words: Benign gynecologic disease, Robotic trache-
lectomy technique, Supracervical hysterectomy.
INTRODUCTION
A resurgence of interest in the supracervical approach to
hysterectomy has occurred over the past 20 years. Early
studies of supracervical hysterectomy (SCH) demon-
strated improved outcomes compared to total hysterec-
tomy, particularly in sexual and urinary function, in addi-
tion to a diminished risk of vaginal prolapse.1–5 Although
such claims did not stand up to subsequent scrutiny,6–9
SCH persisted as many supported retaining the cervix as a
way to facilitate the performance of laparoscopic hyster-
ectomy and make it accessible to a wider population of
surgeons. These trends have created a cohort of post-
hysterectomy patients at risk of persistent or recurrence of
symptoms requiring a subsequent trachelectomy, defined
as the surgical removal of the cervix from an intact uterus,
or the excision of a retained surgical stump. There are
several surgical techniques reported in the literature for
trachelectomy. The preferred surgical approach should be
based on the clinical indication, anatomic considerations,
and the surgeon’s experience.
Several large studies advocating for vaginal trachelectomy
reported less morbidity and shorter hospital stay, com-
pared with laparotomy.10–12 In cases of prolapse, the vag-
inal approach may be preferred12; however, in patients
with chronic pelvic pain or a history of endometriosis or
adhesive disease, laparoscopy may offer an advantage in
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anatomic visualization and dissection.13,14 To date, few
studies have described the surgical techniques and out-
comes of laparoscopic trachelectomy.13,14 This paucity of
information may reflect a lack of widespread adoption of
this approach, which could be due to its technical chal-
lenges.
Robotic surgery may offer potential advantages in over-
coming the challenges of traditional laparoscopy. A thor-
ough literature search on robot-assisted laparoscopic tra-
chelectomy (RT) after SCH revealed only a single case
report and a case series.15,16 We, therefore, elected to
review the surgical outcomes of patients in our health
system who underwent RT after SCH.
MATERIALS AND METHODS
This study was a retrospective chart review of women
who had RT after SCH for benign indications from January
2009 through October 2014. The study was approved by
our institutional review board.
Clinical data were obtained from the patients’ electronic
medical records. Information regarding patient demo-
graphics and medical, surgical, obstetric, and gynecologic
history were collected. The indications for SCH, the mode
of surgery, and the postoperative course were reviewed.
In regard to the RT procedure, we gathered data regarding
the indications for surgery, the preoperative imaging per-
formed, and the time interval between SCH and RT. Any
concomitant procedure at the time of the RT was docu-
mented. Intraoperative findings, postoperative course,
and findings on final pathology were obtained. Patients’
charts were reviewed to document resolution and persis-
tence or worsening of symptoms.
Description of Surgical Technique
Patients in our series were referred to the division of
minimally invasive gynecologic surgery for persistent
symptoms after SCH. All had complex surgical history,
including multiple laparotomies and severe endometrio-
sis, pelvic adhesions or both. Therefore, robotic trache-
lectomy was offered as a safe and effective surgical ap-
proach that could treat all potential pathologies.
Preoperative Papanicolaou smear was obtained in all
cases to rule out cervical dysplasia. All women underwent
an outpatient chemical bowel preparation and were given
perioperative prophylactic antibiotics.
After the induction of general anesthesia, the patient was
placed in a dorsal supine lithotomy position with the feet
in Allen stirrups (Allen Universal, Inc., Cleveland, OH,
USA). A Foley catheter was inserted in the bladder. Given
the increased risk for adhesive disease in the areas of
peritoneal access in such a group of patients, Palmer’s
point was chosen as the preferred technique for obtaining
safe intraperitoneal entry and insufflation. After confirma-
tion of orogastric tube placement by the anesthesia team,
a point in the midclavicular line 3 cm below the left
subcostal margin was injected with 0.25% Marcaine (Hos-
pira Inc, Lake Forest, IL, USA) and entered with a Veress
needle. Entry was confirmed with low pressure (10 mm
Hg) and tympani, with abdominal percussion in the right
upper quadrant. A high-pressure insufflation at 15–20 mm
Hg was favored for initial entry. A 5-mm accessory trocar
was inserted under direct visualization with a 5-mm, 0°
laparoscope in the left upper quadrant.
A cervical manipulator was placed under direct vision
after peritoneal access was gained. For that purpose, we
used a Koh ring from the RUMI manipulator (Cooper
Surgical Inc, Trumbull, CT, USA) sutured to the cervix for
stability then mobilized with a tenaculum, Hulka tenacu-
lum, or Vulsellum clamp.
A 4-robotic arm approach was implemented to allow op-
timal retraction and independence for the console sur-
geon. The 8.5- or 12-mm port for the robotic camera was
placed at the umbilicus. Additional 8-mm ports were
placed 10 cm to the lateral right and lateral left of this
incision at a 15° angle caudad. An additional right lower
quadrant robotic 8-mm port site was placed 10 cm away
from this right lower quadrant incision. The monopolar
scissor, bipolar fenestrated, or Maryland grasper and Pro-
Grasp (Intuitive Surgical, Inc, Sunnyvale, CA, USA) were
used for dissection, energy, and retraction. A 5-mm trocar
allowed for suction and additional retraction.
The dissection proceeded by lysing any adhesions ob-
scuring access to the pelvis. Bilateral ureterolysis was
performed routinely to identify and lateralize the ure-
ters, and on the left, this process often required mobi-
lization of the rectosigmoid at the pelvic brim. Because
the bladder was often scarred over the anterior aspect
of the cervical stump, we performed retrograde filling of
the bladder with irrigation fluid, to ascertain the dissection
plane, and mobilized the bladder caudad by dissecting from
a posterior–lateral to anterior–medial direction. This allowed
for identification of the bladder pillars and cervical branches
of the uterine artery, which were then isolated, coapted with
the bipolar instrument, and cut. At this stage of the dissec-
tion, the vesicocervical junction was usually quite clear, and
both blunt and sharp dissection allowed the bladder to be
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displaced and an adequate width of vaginal fornix to be
available for colpotomy and reapproximation.
A posterior colpotomy was performed after the dissection.
In cases of an obliterated posterior cul-de-sac, proceeding
with entry into the rectovaginal space was also facilitated
by proceeding first with ureterolysis and bladder mobili-
zation. Subsequently, a lateral-to-medial direction of dis-
section across the uterosacral ligaments successfully
opened the Denonvilliers’ fascia of the rectovaginal space,
where fat identified the anterior aspect of the rectum. We
used an EEA sizer (Medtronic, Minneapolis, MN, USA) to
identify the rectum and to place light counterattraction
posteriorly against the posterior deflection of the colpo-
tomizer ring. The colpotomy was performed with focused
energy delivered via a monopolar instrument, the cervix
was retrieved transvaginally, and a 10-mm trocar embed-
ded in an inflatable pneumo occluder balloon was placed
in the vagina for delivery of suture. The vaginal cuff was
closed with running 2-0 barbed sutures in a 2-layered
closure fashion. Reduced pressure visualization confirmed
hemostasis, and routine cystoscopy after administration of
indigo carmine assessed ureteral patency and bladder
integrity.
RESULTS
Eleven patients underwent RT for benign indications dur-
ing the study period. Patient demographic and clinical
information regarding prior SCH is outlined in Table 1.
SCH was most commonly performed for pelvic pain (8/11,
73%) and abnormal uterine bleeding (7/11, 64%). More
than one indication for surgery was present in 64% of the
cases. Laparoscopic and abdominal SCHs were performed
in 55% and 45% of cases, respectively, with a median
uterine weight of 367 g (44–1500 g). In 10 of 11 cases, the
symptoms leading to RT were the same as those experi-
enced prior to SCH. In 1 of the cases, the SCH was
complicated by a pelvic abscess and a vesicovaginal fis-
tula (VVF) necessitating a trachelectomy 1 month after the
surgery.
The median interval time from SCH to seeking medical
help for the persistence or recurrence of symptoms was
6 months (2 weeks to 26 months) and to RT, it was 27
months (1–57 months). Interval pelvic imaging, pelvic
ultrasound followed by pelvic magnetic resonance im-
aging, demonstrated residual uterine tissue, an ovarian
remnant mass, and a pelvic mass/hematosalpinx in 3 of
the 11 patients. Concomitant procedures, mostly ad-
nexal, were performed in 8 of 11 cases (73%) (Table 2).
Ureteral stents were placed bilaterally in 2 cases: one
was a case of VVF that occurred 2 weeks after SCH, and
in the other case, the stents were placed in the presence
of extensive pelvic adhesions because of a history of
multiple laparotomies and severe endometriosis. The
mean length of surgery was 218 minutes (range, 100–
405). The average estimated blood loss during RT was
81 mL (range, 10–200).
There were 3 intraoperative and postoperative complica-
tions in our case series. One patient had a posterior
bladder wall defect secondary to thermal injury sustained
during trachelectomy for severe endometriosis. She pre-
sented with postoperative abdominal pain, fever, and uri-
nary symptoms, and work-up demonstrated the posterior
bladder wall defect. Two weeks after robotic repair, she
presented with a VVF and underwent successful robotic
repair.
In a second case, dissection of fibrotic tissue surround-
ing the left distal ureter caused a superficial adventitial
laceration, necessitating ureteral stent placement for 6
weeks. The third complication was a vaginal cuff he-
matoma that resolved spontaneously with conservative
management.
The median postoperative length of stay after RT was
1 d. Final pathology showed endometriosis in 3 cases,
cervicitis in another 3, and a normal cervix in the
Table 1.
Demographic and Clinical Characteristics of Prior SCH
Variable Value
Age (mean  SD) 39  6.9
BMI (mean  SD) 30  5
Indication for SCH, n (%)
Pelvic pain 8 (73)
Abnormal uterine bleeding 7 (64)
Dysmenorrhea 5 (45)






Interval from SCH to recurrence of symptoms (mo)
Range 0.5–26
Median 6
SCH, supracervical hysterectomy; SD, standard deviation.
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remaining 5 cases. Pathology results did not support the
presence of suspected residual uterine tissue or ovarian
remnant mass demonstrated by imaging studies. How-
ever, a single case of suspected hematosalpinx was
confirmed by pathology.
Six patients reported complete resolution of symptoms
after surgery, and the remaining 5 patients reported a
significant improvement of their symptoms after a fol-
low-up of 12 to 72 months.
DISCUSSION
We present a case series of RT following SCH for benign
indications. Our study demonstrates that trachelectomy can
be considered a definitive therapy for patients with persistent
pelvic pain and vaginal bleeding after SCH. Although trache-
lectomy can be a challenging surgery, our experience sug-
gests that the robotic approach may be a dependable means
of achieving safe and reproducible outcomes.
A growing interest in SCH in the 1990s led to a significant
increase in the rate of patients who underwent this pro-
cedure. Laparoscopic SCH is considered to be technically
less challenging with a lower risk of bladder and ureteral
injury, shorter operative time, and lower blood loss, com-
pared with laparoscopic total hysterectomy.17–19 Early
studies reported that SCH is associated with improved
urinary function, pelvic support, and sexual function,1–5
though subsequent studies cast doubt on these presumed
advantages.6–9 Moreover, the current climate of concern
regarding the risk of the occurrence of occult leiomyosar-
coma after mechanical morcellation of uterine tissue may
shift the pendulum away from SCH.20–22 Nevertheless,
SCH remains an option for patients and physicians; there-
fore, the issue of persistent post-hysterectomy symptoms
associated with retained cervix will continue to present
clinical challenges.
The range of the time interval from SCH to trachelectomy
is very wide, based on the published literature. Conse-
quently, patients’ ages at trachelectomy vary considerably.
This discrepancy can be attributed to the type of symp-
toms presented. Persistent symptoms after SCH, such as
pelvic pain, vaginal bleeding, and dyspareunia, may call
for early intervention, whereas evolving symptoms, such
as pelvic relaxation, may be encountered many years
later, during the postmenopausal period.
Hilger et al.11 showed that the average time between SCH
and trachelectomy for patients with prolapse was 31.1
years as compared to 20.7 years for other indications.
Pasley et al.23 reported pelvic prolapse as the most com-
mon indication for trachelectomy, with a mean time inter-
val of 30 years between surgeries. In our series, most
patients suffered from persistent symptoms after SCH, and
the median interval between procedures was 27 months.
Our results are comparable to those of Okaro et al.14 and
Tam et al.16 who reported a mean interval time of 14 and
48 months, respectively.
The decision regarding the surgical approach to trache-
lectomy should be based on the underlying disease.
Okaro and colleagues14 reported that in all cases where
Table 2.
Demographic and Clinical Characteristics of
Robotic Trachelectomy
Variable Value/n (%)
Age (mean  SD) 42  5.4
Body mass index (mean  SD) 32  6.1
Indication for RT, n (%)
Pelvic pain 8 (73)
Vaginal bleeding 7 (64)
Dyspareunia 3 (27)
Pelvic mass 3 (27)
VVF 1 (9)







Resection of ovarian remnant 1
Tension free obturator tape 1
Resection of VVF 1
Operative time (min)
Range 100–405
Mean 218  88
Estimated blood loss, mL (mean  SD) 81  59.6




No pathologic diagnosis/normal 5
RT, robotic trachelectomy; SCH, supracervical hysterectomy; SD,
standard deviation.
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trachelectomy was performed because of persistent symp-
toms, mainly pelvic pain and vaginal bleeding, the surgi-
cal approach was either laparoscopic (87.5%) or abdom-
inal (12.5%). Tam and colleagues16 also reported a series
of robotic trachelectomy with similar indications. Vaginal
trachelectomy was the preferred surgical approach when
the leading indication for intervention was pelvic organ
prolapse evolving after SCH.11,23,24 In our case series, most
patients underwent RT due to persistent symptoms, in-
cluding pelvic pain and vaginal bleeding, which may be
suggestive of endometriosis as the leading cause of pa-
tients’ complaints.
When removal of the cervical stump is secondary to en-
dometriosis, adhesions, or pelvic mass, the vaginal ap-
proach may present significant technical challenges,
whereas a laparoscopic surgery may facilitate the proce-
dure and optimize patient outcomes. Specifically, laparos-
copy is associated with reduced morbidity, smaller inci-
sions, less pain, shorter recovery time, and shorter
hospital stay, compared with laparotomy.
In 1996, Nezhat et al.13 was the first to publish a series of
6 laparoscopic trachelectomies for persistent pelvic pain
and endometriosis after SCH. Okaro et al.14 reported 14
cases of successful laparoscopic trachelectomy. However,
laparoscopic trachelectomy, as reflected in the paucity of
studies in the literature, has not been widely adopted by
gynecologic surgeons,13,14 perhaps because of the techni-
cal challenges of laparoscopy, including 2-dimensional
view, the fulcrum effect across abdominal wall access, and
paradoxical movement, which may limit dexterity in more
difficult dissections, such as trachelectomy. The robotic
platform provides a 3-dimensional view, improved ergo-
nomics, and intuitive motion and may help overcome
these technical challenges of traditional laparoscopy.
In their series of laparoscopic trachelectomy, Nezhat and
colleagues13 reported a mean operative time of 225 min-
utes and a mean blood loss of 100 mL. Hilger et al.11
evaluated the surgical outcomes of 310 patients after ab-
dominal or vaginal trachelectomy and observed a mean
estimated blood loss of 606 and 193 mL, respectively. Our
study presents favorable results: the mean and median
operative times for RT were 218 and 186 min, respectively,
and estimated blood loss was 81 mL.
The importance of preoperative planning in this group of
patients cannot be overemphasized. Obtaining previous
operative and pathology reports may play a pivotal role in
regard to both counseling the patient and predicting the
need for other surgical consultants, unique instrumenta-
tion, and alternative modes of peritoneal access. The pres-
ence of dense pelvic adhesions may necessitate ureteral
stenting, as stated by Nezhat et al.13 as they reported
stenting in 50% of cases. In our series, we performed
ureterolysis in all cases, whereas placement of ureteral
stents was implemented in 2 cases.
We are aware of several limitations that are inherent in the
retrospective nature of this study. Specifically, the number
of cases presented is small, and hence, the generalization
of our recommendations is limited. Moreover, the results
may be skewed by our selection criteria for the robotic
approach. Finally, no other approach to trachelectomy
was compared to the study group.
CONCLUSION
Our study shows that trachelectomy can be considered a
definitive therapy for patients with unrelieved symptoms
after SCH. Trachelectomy is a potentially challenging sur-
gery; however, our experience suggests that the robotic
approach is a valuable means of achieving safe and re-
producible outcomes.
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